Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy

Heart failure is a severe cardiovascular condition when the heart fails to adequately pump blood or oxygen to support the body’s organs. Sacubitril/valsartan, an emerging angiotensin receptor-neprilysin inhibitor (ARNI) known for its superior efficacy to conventional treatments, has revolutionized t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Neeraj Hiremath, Jayasheela S. Hiremath, Sanatkumar B. Nyamagoud, Agadi Hiremath Viswanatha Swamy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2024-04-01
coleção:	MGM Journal of Medical Sciences
Assuntos:	angiotensin receptor-neprilysin inhibitor cardiorenal syndrome ejection fraction heart failure sacubitril/valsartan
Acesso em linha:	https://doi.org/10.4103/mgmj.mgmj_6_24
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!